Connection

Alessandro Rambaldi to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Alessandro Rambaldi has written about Protein Kinase Inhibitors.
Alessandro Rambaldi
Connection Strength
0.391
Protein Kinase Inhibitors
  1. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia. Handb Exp Pharmacol. 2018; 249:231-250.
    View in: PubMed
    Score: 0.345
  2. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020 09; 34(9):2354-2363.
    View in: PubMed
    Score: 0.026
  3. New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? Expert Opin Biol Ther. 2017 07; 17(7):821-836.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.